Literature DB >> 6796635

Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes.

M C Hammer, A L Baltch, N T Sutphen, R P Smith, J V Conroy.   

Abstract

The maximum phagocytic and bactericidal capabilities of normal human PMNs against a seroresistant strain of Pseudomonas aeruginosa were evaluated by morphological observation, uptake of radiolabeled bacteria, and quantitative killing methods. The number of bacteria killed per PMN increased from 3 to 23 as the bacteria-to-PMN ratio was increased from 3:1 to 100:1. Conversely, the percent of bacteria killed decreased from 94% to 3%. In monolayers, an increase in the inoculum from 10(5) to 10(8) cfu/ml was associated with greater phagocytosis and a sixfold increase in PMNs containing greater than or equal to 5 bacteria/PMN. With the use of 75Se-labeled P. aeruginosa, optimal phagocytosis was observed with 10 to 20 bacteria/PMN in 20% NPS. Maximum uptake of 70% occurred in 40 min. No difference was observed in the uptakes of live or heat-killed bacteria. The maximum number of bacteria ingested per PMN was 32 +/- 5 at the highest ratio tested (100:1). The use of altered opsonic sources indicated the need for the classical complement pathway for optimal phagocytosis. Thus study describes the requirements and necessary standardization parameters that were found to be essential for a highly reproducible method for measuring phagocytosis and killing of P. aeruginosa by normal human PMNs. This method could be employed for clinical assessment of partial opsonic or PMN dysfunction in the study of the interaction of PMNs and P. aeruginosa.

Entities:  

Mesh:

Year:  1981        PMID: 6796635

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

Review 1.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Human granulocyte activity against moxalactam-induced filamentous forms of Pseudomonas aeruginosa.

Authors:  M C Hammer; A L Baltch; R P Smith; J V Conroy; M Bishop; P Michelsen; L Hill
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

3.  Determination of maximal bactericidal activity in human granulocytes.

Authors:  H Hülsheger; W Stangel; J Schmidt; J Potel
Journal:  Blut       Date:  1985-03

4.  Evidence for bistable bacteria-neutrophil interaction and its clinical implications.

Authors:  Roy Malka; Baruch Wolach; Ronit Gavrieli; Eliezer Shochat; Vered Rom-Kedar
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.

Authors:  Travis S Walker; Kerry L Tomlin; G Scott Worthen; Katie R Poch; Jonathan G Lieber; Milene T Saavedra; Michael B Fessler; Kenneth C Malcolm; Michael L Vasil; Jerry A Nick
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Intratracheal instillation of neutrophils rescues bacterial overgrowth initiated by trauma damage-associated molecular patterns.

Authors:  Kiyoshi Itagaki; Ingred Riça; Jing Zhang; Dave Gallo; Melissa DePrato; Leo E Otterbein; Carl J Hauser
Journal:  J Trauma Acute Care Surg       Date:  2017-05       Impact factor: 3.313

7.  Bistability and bacterial infections.

Authors:  Roy Malka; Eliezer Shochat; Vered Rom-Kedar
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

8.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions.

Authors:  A L Baltch; M C Hammer; R P Smith; T G Obrig; J V Conroy; M B Bishop; M A Egy; F Lutz
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

10.  Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.

Authors:  R G Cowan; G B Winnie
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.